File(s) under embargo

307

days

24

hours

until file(s) become available

Biased Antagonists of CXCR4 Avoid the Development of Antagonist Tolerance

thesis
posted on 01.08.2019 by Ben Hitchinson
Despite reported tolerance to antagonists of multiple GPCRs, very few studies provide mechanistic insight and strategies to avoid it [50, 133, 134]. Tolerance to the only FDA–approved CXCR4 receptor antagonist AMD3100 can occur and significantly limits the potential to target the receptor in a variety of pathologies [50]. This tolerance is associated with increased receptor expression on the cell surface. In this thesis, we have investigated the mechanism of tolerance to AMD3100 and developed strategies to avoid it. We hypothesize that accumulation of CXCR4 on the cell surface leads to the development of tolerance, at least in part, due to the inhibition of receptor endocytosis by AMD3100. Thus, we hypothesized that antagonists that inhibited G protein signalling but not receptor endocytosis would avoid the development of tolerance. Few compounds of this type, called biased antagonists, have been discovered [135, 136]. By understanding the mechanisms through which tolerance develops, we believe that future pharmaceutical development will benefit from rational design of inhibitors that avoid these processes.

Categories

Keyword(s)

History

Advisor

Gaponenko, Vadim

Chair

Gaponenko, Vadim

Department

Biochemistry and Molecular Genetics

Degree Grantor

University of Illinois at Chicago

Degree Level

Doctoral

Degree name

PhD, Doctor of Philosophy

Committee Member

Ackerman, Steven J Caffrey, Michael Hay, Nissim Tyner, Angela Gartel, Andrei

Submitted date

August 2019

Thesis type

application/pdf

Language

en

Issue date

23/08/2019

Exports

Categories

Keyword(s)

Exports